IP Verse

Combination Medicament Comprising Il-12 And An Agent For Blockade Of T-Cell Inhibitory Molecules For Tumour Therapy

Patent No. EP3351261 (titled "Combination Medicament Comprising Il-12 And An Agent For Blockade Of T-Cell Inhibitory Molecules For Tumour Therapy") was filed by Universitt Zrich on Oct 10, 2012. The application was issued on Jun 2, 2021.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (6)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
KRAUS & WEISERTMar 2, 2022HIEBL
JAMES POOLEMar 2, 2022CARPMAELS & RANSFORD
KRAUS & WEISERTMar 2, 2022HOFFMANN EITLE
WEINZIERL, GERHARDMar 2, 2022SCHIWECK WEINZIERL KOCH PATENTANWALTE PARTNERSCHAFT MBB
SANOFIMar 2, 2022CMS CAMERON MCKENNA NABARRO OLSWANG
JG OPPOSITIONSMar 1, 2022DRYWOOD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

EP3351261

UNIVERSITT ZRICH
Application Number
EP18160057A
Filing Date
Oct 10, 2012
Status
Revoked
Jun 10, 2025
Publication Date
Jun 2, 2021
External Links
Slate, Register , Google Patents